(Q37992526)

26 August 2017

title

Myeloperoxidase production by macrophage and risk of atherosclerosis (English)

1 reference

26 August 2017

0 references

1 reference

2

Wolfgang Koenig

1 reference

26 August 2017

Mahir Karakas

1

1 reference

26 August 2017

language of work or name

1 reference

1 June 2012

1 reference

Current Atherosclerosis Reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

277-283

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-012-0242-3

26 August 2017

exact match

0 references

cites work

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Nitric oxide is a physiological substrate for mammalian peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Formation of dysfunctional high-density lipoprotein by myeloperoxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase, modified lipoproteins, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Statins downregulate myeloperoxidase gene expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Prognostic value of myeloperoxidase in patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Plasma myeloperoxidase is related to the severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0242-3

Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis

21 January 2018

1 reference

12 December 2020

Hydrogen peroxide production during experimental protein glycation

1 reference

12 December 2020

High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study

1 reference

12 December 2020

Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase

1 reference

12 December 2020

Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils

1 reference

12 December 2020

Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial

1 reference

12 December 2020

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

1 reference

12 December 2020

10.1007/S11883-012-0242-3

Identifiers

DOI

1 reference

26 August 2017

1 reference